Table 1 Clinicopathological characteristics of 115 patients undergoing DP
Variable | All patients (n = 115) |
|---|---|
Gender, n (%) | Â |
 Male | 34 (29.6) |
 Female | 81 (70.4) |
Age (y), median (IQR) | 53.0 (45.5–62.0) |
BMI (kg/m2), n (%) | Â |
 < 25 | 63 (54.8) |
 ≥ 25 | 52 (45.2) |
Hypertension, n (%) | Â |
 No | 96 (83.5) |
 Yes | 19 (16.5) |
Diabetes, n (%) | Â |
 No | 95 (82.6) |
 Yes | 20 (17.4) |
Smoking, n (%) | Â |
 No | 93 (80.9) |
 Yes | 22 (19.1) |
Alcohol abuse, n (%) | Â |
 No | 99 (86.1) |
 Yes | 16 (13.9) |
Hemoglobin (g/L), median (IQR) | 131 (122–140) |
Prealbumin (g/L), median (IQR) | 210 (184–251) |
Albumin (g/L), n (%) | Â |
 ≥ 35 | 90 (78.3) |
 < 35 | 25 (21.7) |
CA199 (KU/L), median (IQR) | 16.2 (5.80–76.8) |
Operation time (min), median (IQR) | 287 (231–352) |
Blood loss (mL), median (IQR) | 300 (200–550) |
Surgical approach, n (%) | Â |
 Laparoscopic | 16 (13.9) |
 Open | 99 (86.1) |
Ligation of main pancreatic duct, n (%) | Â |
 No | 54 (47.0) |
 Yes | 61 (53.0) |
Pancreatic stump treatment, n (%) | Â |
 Endo GIA stapler | 30 (26.1) |
 Suture | 85 (73.9) |
Pathology, n (%) | Â |
 PDAC | 36 (31.3) |
 Cystic | 45 (39.13) |
 Pancreatitis | 10 (8.7) |
 Neuroendocrine | 13 (11.3) |
 SPTP | 9 (7.83) |
 Others | 2 (1.74) |
Pancreas thickness (mm), median (IQR) | 17.2 (15.3–20.2) |
Pancreas texture, n (%) | Â |
 Hard | 69 (60.0) |
 Soft | 46 (40.0) |
Splenectomy, n (%) | Â |
 No | 56 (48.7) |
 Yes | 59 (51.3) |
CR-POPF, n (%) | Â |
 No | 77 (67.0) |
 Yes | 38 (33.0) |